Related references
Note: Only part of the references are listed.An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables
Anne van Rongen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2022)
Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations
Trevor N. Johnson et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2022)
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper
Anne Smits et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Prediction of glomerular filtration rate maturation across preterm and term neonates and young infants using inulin as marker
Yunjiao Wu et al.
AAPS JOURNAL (2022)
From immature pharmacotherapy towards pharmacotherapy of the immature
Karel Allegaert et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2022)
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
Sara N. Salerno et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
A best practice framework for applying physiologically-based pharmacokinetic modeling to pediatric drug development
Trevor N. Johnson et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2021)
Does Birth as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias
Farzaneh Salem et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance
Neel Deferm et al.
CLINICAL PHARMACOKINETICS (2021)
Authors' Reply to Voller et al: Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2021)
Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II
Swantje Voller et al.
CLINICAL PHARMACOKINETICS (2021)
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
B. D. van Groen et al.
PHARMACOLOGICAL REVIEWS (2021)
Application of Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial Effect
Harshith Neeli et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Physiologically based pharmacokinetic modelling of acetaminophen in preterm neonates-The impact of metabolising enzyme ontogeny and reduced cardiac output
Olusola Olafuyi et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2021)
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants
Samit Ganguly et al.
CLINICAL PHARMACOKINETICS (2021)
Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) and Ductus Arteriosus Closure After Premature Birth
Naim Bouazza et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Sex differences in postnatal weight gain trajectories of extremely preterm newborns
Fu-Sheng Chou et al.
JOURNAL OF PERINATOLOGY (2021)
Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2020)
A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2020)
Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants
Paul R. V. Malik et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
Anne Smits et al.
FRONTIERS IN PHARMACOLOGY (2020)
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
Sumit Basu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions
Karel Allegaert et al.
FRONTIERS IN PEDIATRICS (2020)
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
Lukas Kovar et al.
PHARMACEUTICS (2020)
Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
Laurens F. M. Verscheijden et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Prediction of Clearance and Dose ofMidazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling
Najia Mansoor et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Personalized weight change prediction in the first week of life
Melanie Wilbaux et al.
CLINICAL NUTRITION (2019)
Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs
Khaled Abduljalil et al.
CLINICAL PHARMACOKINETICS (2019)
A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents
Iftekhar Mahmood et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
O07 Predictive performance of a physiologically based pharmacokinetic model of caffeine in the preterm population
A Pansari et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
Larger Dose Reductions of Vancomycin Required in Neonates with Patent Ductus Arteriosus Receiving Indomethacin versus Ibuprofen
S. Cristea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
WB-PBPK approach in predicting zidovudine pharmacokinetics in preterm neonates
Liuya Wei et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2019)
Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials
Jonathan M. Davis et al.
JOURNAL OF PEDIATRICS (2019)
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study
David Hahn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute
Anne Smits et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the US Food and Drug Administration's Office of Clinical Pharmacology
Manuela Grimstein et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants
Jacqueline G. Gerhart et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Misconceptions and issues regarding allometric scaling during the drug development process
Iftekhar Mahmood
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Development of growth equations from longitudinal studies of body weight and height in the full term and preterm neonate: From birth to four years postnatal age
John A. Troutman et al.
BIRTH DEFECTS RESEARCH (2018)
The use of PBPK modeling across the pediatric age range using propofol as a case
Robin Michelet et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Chie Emoto et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates
Janneke M. Brussee et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling
Iftekhar Mahmood et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates
Robert M. Ward et al.
PEDIATRIC RESEARCH (2017)
Evidence-based drug treatment for special patient populations through model-based approaches
Elke H. J. Krekels et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
PBPK in Preterm and Term Neonates: A Review
Robin Michelet et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond
Karel Allegaert et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Improving Realism in Clinical Trial Simulations via Real-World Data
Holly Kimko et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
SLC22A1/OCT1 Genotype Affects O-desmethyltramadol Exposure in Newborn Infants
Maja Matic et al.
THERAPEUTIC DRUG MONITORING (2016)
How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology Approach
Trevor N. Johnson et al.
DRUG METABOLISM AND DISPOSITION (2016)
Neonatal Drug Therapy: The First Frontier of Therapeutics for Children
K. Allegaert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
Karina Claassen et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants
Elke H. J. Krekels et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Changes in Individual Drug-Independent System Parameters during Virtual Paediatric Pharmacokinetic Trials: Introducing Time-Varying Physiology into a Paediatric PBPK Model
Khaled Abduljalil et al.
AAPS JOURNAL (2014)
The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults
Chenguang Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Neonatal clinical pharmacology
Karel Allegaert et al.
PEDIATRIC ANESTHESIA (2014)
Human renal function maturation: a quantitative description using weight and postmenstrual age
Malin M. Rhodin et al.
PEDIATRIC NEPHROLOGY (2009)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Renal drug clearance in preterm neonates: Relation to prenatal growth
Karel Allegaert et al.
THERAPEUTIC DRUG MONITORING (2007)
Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life
K Allegaert et al.
BIOLOGY OF THE NEONATE (2004)
Share Paper
